Warfarin Dose Management for Fluctuating INR
For your current INR of 3.96, omit the next 1-2 doses of warfarin and reduce your weekly dose by approximately 10-15% when you resume, then recheck your INR within 3-5 days. 1
Immediate Management of Current INR 3.96
Since your INR is between 3.2 and 4.0 without bleeding:
- Omit 1-2 doses of warfarin (skip today and possibly tomorrow)
- Do not take vitamin K - this is reserved for INR >5 or bleeding risk 1
- Recheck INR in 3-5 days to ensure it's falling appropriately
Dose Adjustment Strategy
Your current regimen provides:
- Weekly total: 20 mg (2.5 mg × 2 days + 3.75 mg × 4 days = 20 mg/week)
Recommended new weekly dose: 17.5-18 mg/week (approximately 10-12% reduction)
Practical dosing options:
- Option 1: 2.5 mg daily (17.5 mg/week) - simplest approach
- Option 2: 2.5 mg × 5 days + 3.75 mg × 1 day (16.25 mg/week) - if more reduction needed
Understanding Your INR Pattern
Your fluctuation (3.96 → 2.65 → 3.96) suggests instability rather than random variation. This pattern warrants dose adjustment, not "watchful waiting." 2 While guidelines suggest maintaining dose for single out-of-range values of 0.5 above therapeutic range, your recurrent elevation to 3.96 indicates your current dose is too high.
Monitoring Schedule
Critical pitfall: The 2-week monitoring interval recommended for stable patients 2 does not apply to your situation with recurrent supratherapeutic INRs.
- Week 1: Check INR 3-5 days after resuming reduced dose
- Week 2: Check INR again if first result is 2.0-3.0
- Weeks 3-4: Weekly monitoring until you achieve 2-3 consecutive therapeutic INRs
- Then: Gradually extend to every 2-4 weeks once stable 2
Key Clinical Considerations
Bleeding risk: Your INR of 3.96 carries increased bleeding risk 1, though absolute daily risk remains low. However, recurrent elevations compound this risk over time.
Why not just "watch and wait"? Research shows that for recurrent out-of-range INRs (not isolated values), dose adjustment is necessary 3, 4. Your pattern of returning to 3.96 after previously being 3.96 indicates systematic overanticoagulation, not random variation.
Avoid over-correction: Do not reduce your dose by more than 20% of the weekly total 5, 6. Excessive dose reductions (>20%) can cause the INR to drop too low, creating thrombotic risk.
Factors to Investigate
Look for causes of INR instability:
- Dietary changes in vitamin K intake (leafy greens, certain oils)
- New medications or supplements
- Alcohol consumption changes
- Illness affecting liver function or absorption
- Medication adherence - confirm you're taking doses as prescribed
Target INR range: Assuming your target is 2.0-3.0 (standard for most indications) 7. If your indication requires different targets (e.g., mechanical valve), adjust accordingly.